Stanford University researchers have discovered why some people with attention deficit hyperactivity disorder may do well on ...

Hundreds of thousands of Australians who use a certain type of ADHD medication will be forced to use amphetamine-based ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Medically reviewed by Paria Sanaty Zadeh, PharmD Attention-deficit/hyperactivity disorder (ADHD) medications can be ...

Methylphenidate (Ritalin, MPH) is a psychostimulant drug approved for treatment of attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy.It may also be ...

Methylphenidate has a possibility to interact with more drugs. These interactions are harmful. Drug interactions can be prevented by avoiding unwanted drug combinations.

Methylphenidate was associated with a small increased risk for cardiovascular events in individuals taking the drug for more than 6 months in a new cohort study. The retrospective, population ...

Ritalin is the latest attention deficit hyperactivity disorder (ADHD) medication in short supply—after a months-long Adderall shortage—leaving patients who rely on these drugs to manage daily ...

This has been methylphenidate versus placebo for treating fatigue in people with advanced cancer, randomized, double-blind, multicenter, placebo-controlled clinical trial. And again, this is a dual ...

D’Aiello B, Gessi L, Menghini D, Vicari S, De Rossi P. Sleep disturbances in children with ADHD on methylphenidate monotherapy: the role of dysregulation profile. Sleep Med . 2025:128:153-158 ...